Aspirin may cut pancreatic cancer risk, but should everyone take it?
June 27, 2014
| By Joely Johnson Mork
Aspirin may cut pancreatic cancer risk, according to a new study, but last month the FDA advised against healthy people taking it to prevent strokes and heart attacks due to potential side effects. Fred Hutch researchers help sort out the new findings.
National Cancer Institute grant to evaluate genetic susceptibility for Barrett’s esophagus and esophageal adenocarcinoma
Nov. 2, 2009
| By Colleen Steelquist
Dr. Tom Vaughan, an epidemiologist in the Fred Hutchinson Cancer Research Center's Public Health Sciences Division, has received a three-year, $7.9 million grant from the National Cancer Institute to study genetic susceptibility for Barrett’s esophagus and esophageal adenocarcinoma, a rapidly fatal cancer whose incidence has increased more than 500 percent in the past 30 years, faster than any other cancer in the United States.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.